This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Epigenomics Ag. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Munich, DE (2011)
- Muenchen, DE (2012)
Company Filing History:
Years Active: 2011-2012
Title: The Innovative Contributions of Matthias Ebert in Colon Health
Introduction: Matthias Ebert, a distinguished inventor based in Muenchen, Germany, has significantly impacted the field of medical diagnostics with his innovative work. Holding two patents, Ebert has focused his research on colon proliferative disorders, paving the way for improved detection and treatment of these medical conditions.
Latest Patents: Matthias Ebert's latest patents include groundbreaking methods and nucleic acids designed to analyze colon proliferative disorders. The first patent, titled "Methods and nucleic acids for analysis of colon proliferative disorders," offers techniques, nucleic acids, and kits that facilitate the detection of such disorders. This invention reveals genomic sequences and their methylation patterns, providing crucial utility for enhanced diagnosis and treatment of affected patients. The second patent, "Methods and nucleic acids for the detection of metastasis of colon cell proliferative disorders," advances the capability to identify metastasis of these disorders. Similar to his first patent, this invention discloses genomic sequences and methylation patterns that aid in the improved detection of metastasis, fostering better diagnosis and patient outcomes.
Career Highlights: Currently, Matthias Ebert is affiliated with Epigenomics AG, a company known for its focus on genomics and diagnostics. His work there is pivotal in bridging the gap between research innovation and practical medical applications, ultimately contributing to the enhancement of patient care.
Collaborations: Throughout his career, Matthias has collaborated with notable professionals in the field, including Catherine E Lofton-Day. These partnerships have fostered the exchange of ideas and expertise, further promoting advancements in colon health diagnostics.
Conclusion: Matthias Ebert's inventions and relentless pursuit of innovation in the realm of colon proliferative disorders highlight his commitment to improving healthcare solutions. With his patents enabling better detection and treatment options, Ebert continues to be a crucial figure in the ongoing efforts to combat colon health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile